Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07443371) titled 'Effect of Transfer Energy Capacitive and Resistive Therapy on Palmar Fibromatosis' on Feb. 25.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).

Primary Sponsor: Cairo University

Condition: Palmar Fibromatosis

Intervention: Device: Transfer Energy Capacitive and Resistive (TECAR) therapy

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: March 2, 2026

Target Sample Size: 36

Countries of Recruitment: Egypt

To know more, visit https://clinicaltrials.gov/study/NCT...